Literature DB >> 29392477

Antihypertensive-related adverse drug reactions among older hospitalized adults.

Tariq M Alhawassi1,2, Ines Krass2, Lisa G Pont3.   

Abstract

Background Antihypertensive medications are commonly used for a wide range of indications, yet it is unknown to what extent older adults are at risk of adverse drug reactions (ADRs) associated with their antihypertensive medication use. Objective The aim of this study was to determine the prevalence and characteristics of antihypertensive-related ADRs on hospital admission. Setting Metropolitan teaching hospital in Sydney, Australia. Method A retrospective cross-sectional audit of 503 older patients (≥ 65 years) admitted to hospital was conducted. Potential ADRS were identified from the medical record. Two independent clinical pharmacists reviewed each potential ADR using validated tools for causality, severity, preventability and contribution to hospitalization. Characteristics associated with an increased ADR risk among antihypertensive users were identified via logistic regression. Main outcome measure Antihypertensive related ADRs. Results Antihypertensives were used on admission by 68% of the cohort and the prevalence of 'definite/probable' antihypertensive-related ADRs among antihypertensive users was 16.4%. Antihypertensive medications were associated with a threefold ADR risk (OR = 3.09, 95% CI 1.85-5.16). Angiotensin II Receptor Blockers (ARB), impaired renal function, recent medication changes and previous history of allergy or ADR were all associated with an increased risk of experiencing an ADR. Conclusions ADRS associated with antihypertensive medicines were relatively common among older adults admitted to hospital. Increased awareness of those older persons who are most at risk of experiencing an antihypertensive-related ADR in the clinical setting may lead to early detection and minimization of ADR associated harms.

Entities:  

Keywords:  Acute care; Adverse reaction; Antihypertensive medication; Australia; Drug utilization; Medication safety; Older adult

Mesh:

Substances:

Year:  2018        PMID: 29392477     DOI: 10.1007/s11096-017-0583-7

Source DB:  PubMed          Journal:  Int J Clin Pharm


  23 in total

1.  A brief clinical instrument to classify frailty in elderly people.

Authors:  K Rockwood; K Stadnyk; C MacKnight; I McDowell; R Hébert; D B Hogan
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

2.  Performance of trigger tools in identifying adverse drug events in emergency department patients: a validation study.

Authors:  Andrei Karpov; Catherine Parcero; Catherine P Y Mok; Chandima Panditha; Eugenia Yu; Linda Dempster; Corinne M Hohl
Journal:  Br J Clin Pharmacol       Date:  2016-07-08       Impact factor: 4.335

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older.

Authors:  Tessa K Morgan; Margaret Williamson; Marie Pirotta; Kay Stewart; Stephen P Myers; Joanne Barnes
Journal:  Med J Aust       Date:  2012-01-16       Impact factor: 7.738

Review 5.  Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.

Authors:  Chuenjid Kongkaew; Peter R Noyce; Darren M Ashcroft
Journal:  Ann Pharmacother       Date:  2008-07-01       Impact factor: 3.154

6.  Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study.

Authors:  Anders Helldén; Ulf Bergman; Mia von Euler; Maria Hentschke; Ingegerd Odar-Cederlöf; Gunnar Ohlén
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 7.  Hypertension in Older Persons: A Systematic Review of National and International Treatment Guidelines.

Authors:  Tariq M Alhawassi; Ines Krass; Lisa G Pont
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-31       Impact factor: 3.738

8.  Recognition of adverse drug events in older hospitalized medical patients.

Authors:  Joanna E Klopotowska; Peter C Wierenga; Susanne M Smorenburg; Clementine C M Stuijt; Lambertus Arisz; Paul F M Kuks; Marcel G W Dijkgraaf; Loraine Lie-A-Huen; Sophia E de Rooij
Journal:  Eur J Clin Pharmacol       Date:  2012-06-07       Impact factor: 2.953

9.  Using prospective clinical surveillance to identify adverse events in hospital.

Authors:  Alan J Forster; Jim R Worthington; Steven Hawken; Michael Bourke; Fraser Rubens; Kaveh Shojania; Carl van Walraven
Journal:  BMJ Qual Saf       Date:  2011-03-01       Impact factor: 7.035

10.  Prediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score).

Authors:  Nibu Parameswaran Nair; Leanne Chalmers; Michael Connolly; Bonnie J Bereznicki; Gregory M Peterson; Colin Curtain; Ronald L Castelino; Luke R Bereznicki
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

View more
  5 in total

1.  This is not the time to modify a HTN regimen.

Authors:  Calvin Grubbs; Laura Morris
Journal:  J Fam Pract       Date:  2021-07       Impact factor: 0.493

Review 2.  The Effect of Continuous Positive Airway Pressure Therapy on Obstructive Sleep Apnea-Related Hypertension.

Authors:  Ronni Baran; Daniela Grimm; Manfred Infanger; Markus Wehland
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

3.  Detection of adverse drug events in e-prescribing and administrative health data: a validation study.

Authors:  Bettina Habib; Robyn Tamblyn; Nadyne Girard; Tewodros Eguale; Allen Huang
Journal:  BMC Health Serv Res       Date:  2021-04-23       Impact factor: 2.655

4.  Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol.

Authors:  Elisabeth Pedersen; Raul Primicerio; Kjell H Halvorsen; Anne Elise Eggen; Beate Hennie Garcia; Henrik Schirmer; Marit Waaseth
Journal:  Eur J Clin Pharmacol       Date:  2022-01-21       Impact factor: 2.953

5.  Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study.

Authors:  Fei Yee Lee; Farida Islahudin; Mohd Makmor-Bakry; Hin-Seng Wong; Sunita Bavanandan
Journal:  Int J Clin Pharm       Date:  2021-03-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.